STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy
NCT: NCT07655284 · WITHDRAWN
Brief Summary
Radical Cystectomy (RC) remains the gold standard for localized muscle-invasive bladder cancer (MIBC); however, use of ureteral stents at time of surgery remains controversial without level 1 evidence to comment on risks or benefits of their use. RC complications commonly include urinary tract infections (UTIs), pyelonephritis, ureteroileal leakage and stenosis, and can occur with either ileal conduit or orthotopic neobladder diversions. Traditionally, ureteral stents are thought to support anastomotic healing and reduce the risk of anastomotic leakage and strictures; however, emerging evidence from retrospective studies suggests that stent use may paradoxically increase rates of postoperative morbidity. This randomized, multicenter and prospective study aims to compare 30-day postoperative complication rates between stented and non-stented urinary diversions in patients undergoing RC for MIBC, in both ileal conduit or neobladder with either robotic or open approaches.
Frequently Asked Questions
What is STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy?
STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy is a clinical trial registered under NCT07655284. Current status: WITHDRAWN.
What is the status of NCT07655284?
The current status of NCT07655284 (STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy) is: WITHDRAWN.
When did STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy start?
STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy started on 2026-09-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.